Advertisements


We are Sorry, This Page doesn't Exist


Mersana Therapeutics, Inc. (MRSN) CEO Anna Protopapas on Q3 2019 Results - Earnings Call Transcript

Mersana Therapeutics, Inc. (MRSN) CEO Anna Protopapas on Q3 2019 Results - Earnings Call Transcript.....»»

Category: topSource: seekingalphaNov 10th, 2019

Mersana Therapeutics, Inc. (MRSN) CEO Anna Protopapas on Q2 2019 Results - Earnings Call Transcript

Mersana Therapeutics, Inc. (MRSN) CEO Anna Protopapas on Q2 2019 Results - Earnings Call Transcript.....»»

Category: topSource: seekingalphaAug 10th, 2019

Mersana Therapeutics, Inc. (MRSN) Q1 2019 Earnings Call Transcript

MRSN earnings call for the period ending March 31, 2019......»»

Category: topSource: foxnewsMay 17th, 2019

Mersana Therapeutics, Inc. (MRSN) CEO Anna Protopapas on Q1 2019 Results - Earnings Call Transcript

Mersana Therapeutics, Inc. (MRSN) CEO Anna Protopapas on Q1 2019 Results - Earnings Call Transcript.....»»

Category: topSource: seekingalphaMay 12th, 2019

Mersana Therapeutics (MRSN) CEO Anna Protopapas on Q4 2018 Results - Earnings Call Transcript

Mersana Therapeutics (MRSN) CEO Anna Protopapas on Q4 2018 Results - Earnings Call Transcript.....»»

Category: topSource: seekingalphaMar 9th, 2019

Mersana Therapeutics" (MRSN) CEO Anna Protopapas on Q1 2018 Results - Earnings Call Transcript

Mersana Therapeutics" (MRSN) CEO Anna Protopapas on Q1 2018 Results - Earnings Call Transcript.....»»

Category: topSource: seekingalphaMay 14th, 2018

Fate Therapeutics Q2 Earnings Preview

Fate Therapeutics (NASDAQ: FATE) releases its next round of earnings Monday. Here's Benzinga's essential guide to Fate Therapeutics' Q2 earnings report. read more.....»»

Category: blogSource: benzingaAug 6th, 2018

Fate Therapeutics Q2 Earnings Preview

Fate Therapeutics (NASDAQ: FATE) releases its next round of earnings Monday. Here's Benzinga's essential guide to Fate Therapeutics' Q2 earnings report. Earnings and Revenue Analysts are expecting F.....»»

Category: earningsSource: benzingaAug 6th, 2018

Mersana Therapeutics" (MRSN) CEO Anna Protopapas on Q2 2018 Results - Earnings Call Transcript

Mersana Therapeutics" (MRSN) CEO Anna Protopapas on Q2 2018 Results - Earnings Call Transcript.....»»

Category: topSource: seekingalphaAug 15th, 2018

Q3 Earnings Preview For Sarepta Therapeutics

Sarepta Therapeutics, Inc. (NASDAQ: SRPT) announces its next round of earnings this Wednesday, Oct. 24. Here's Benzinga's advanced look at Sarepta's Q3 earnings report. read more.....»»

Category: blogSource: benzingaOct 24th, 2018

A Preview Of Halozyme Therapeutics Q3 Earnings

Halozyme Therapeutics, Inc. (NASDAQ: HALO) unveils its next round of earnings this Tuesday, Nov. 6. Get prepared with Benzinga's ultimate previ.....»»

Category: earningsSource: benzingaNov 6th, 2018

A Preview Of Halozyme Therapeutics Q3 Earnings

Halozyme Therapeutics, Inc. (NASDAQ: HALO) unveils its next round of earnings this Tuesday, Nov. 6. Get prepared with Benzinga's ultimate preview for Halozyme Therapeutics' Q3 earnings. read more.....»»

Category: blogSource: benzingaNov 6th, 2018

Mersana Therapeutics (MRSN) CEO Anna Protopapas on Q3 2018 Results - Earnings Call Transcript

Mersana Therapeutics (MRSN) CEO Anna Protopapas on Q3 2018 Results - Earnings Call Transcript.....»»

Category: topSource: seekingalphaNov 13th, 2018

United Airlines Q1 Earnings Preview: Analyst Estimates, Safety Concerns, Underperformance To Delta — Key Items To Watch

An earnings preview for United Airlines with key items to watch in the upcoming first quarter financial results. read more.....»»

Category: blogSource: benzingaApr 15th, 2024

CarMax Q4 Earnings Preview: Analyst Estimates, Multi-Year Recovery, Key Items To Watch

CarMax is expected to report fourth-quarter revenue up year-over-year, which would mark an improvement on the decline in the third quarter. Here are the key numbers and items to watch. Latest Ratings for .....»»

Category: blogSource: benzingaApr 10th, 2024

Earnings Preview for Dick"s Sporting Goods

Dick's Sporting Goods (NYSE:DKS) announces its next round of earnings this Wednesday, May 26. Here is Benzinga's everything-that-matters guide for this Wednesday's Q1 earnings announcement. read more.....»»

Category: blogSource: benzingaMay 25th, 2021

Earnings Outlook: Walmart earnings preview: Rival Target likely saw more benefit from stimulus spending

Target benefits from the wide variety of merchandise categories that it sells, analysts say.....»»

Category: topSource: marketwatchMay 15th, 2021

Earnings Outlook for Onconova Therapeutics

Onconova Therapeutics (NASDAQ:ONTX) announces its next round of earnings this Monday, May 17. Here is Benzinga's everything-that-matters guide for this Monday's .....»»

Category: earningsSource: benzingaMay 14th, 2021

Niu Technologies"s Earnings: A Preview

On Monday, May 17, Niu Technologies (NASDAQ:NIU) will release its latest earnings report. Here is Benzinga's outlook for the company. N.....»»

Category: earningsSource: benzingaMay 14th, 2021

Flexion Therapeutics: Q1 Earnings Insights

Shares of Flexion Therapeutics (NASDAQ:FLXN) rose in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share rose 40.00% year over year to ($0.57), which missed the estimate of ($0.52). read more.....»»

Category: blogSource: benzingaMay 12th, 2021